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Abstract. The biocompatibility and osteoconductive potential of Bonelike

 and Bonelike

/PLGA 
hybrid materials were evaluated through subcutaneous and tibiae implantations for a 4 week period. 
Qualitative histology was performed to evaluate new bone formation and characterise bone-implant 
interface and results showed that Bonelike

/PLGA hybrid materials promote extensive bone 
growth.  After the 4 week implantation period, Bonelike

 resorption was recognized, which may be 
due to the presence of resorbable  and -tricalcium phosphate phases. 
Introduction 
Reconstructive surgery has been a challenging clinical problem in terms of repairing large bone 
defects, such as in the cases of arthroplasty revision surgeries, facial reconstructions, healing of 
excised bone cysts and tumours [1]. There are a number of treatment strategies suitable for solving 
these clinical cases, which include utilization of autographs and allografts. However, there are 
limitations when using auto grafts due to restricted bone supply [2] and allografts due to the 
possibility of inducing transmissible diseases [3]. As an alternative, it has been proposed the use of 
alloplastic materials, which comprise the class of synthetic materials, such as hydroxyapatite (HA) 
and other calcium phosphate-based ceramics [4]. These biomaterials are similar to the inorganic 
phase of bone [5], are osteoconductive [6] and have been used clinically. A preventive treatment 
against post-operative infections is a common clinical procedure, which is based on systemic 
antibiotic therapy [7]. Nevertheless, this type of treatment has various systemic adverse effects, 
such as the development of bacterial resistance and the fact that only a small amount of the dose 
reaches the surgical site [7]. Therefore, much attention is being directed towards implantable 
calcium phosphates that locally deliver therapeutic molecules and therefore prevent bacterial 
infection [7] with simultaneous new bone formation. Bonelike

 is a synthetic bone graft material 
that has been designed for clinical applications of bone regeneration. Its chemical composition 
mimics the mineral phase of bone tissues and also comprises some percentages of -tricalcium 
phosphate (TCP), Ca3(PO4)2, and -TCP. These phases are known to degrade in physiological 
environment, however is difficult to chemically bind therapeutic molecules to the Bonelike

 surface 
in a controlled manner. On the contrary, synthetic polymers, such as the poly (D,L-lactide-co-
glycolide) (PLGA) are highly biodegradable and may be used in controlled drug delivery 
applications [8].  
The purpose of this work was to assess the osteoconductive potential of novel Bonelike

/PLGA 
hybrid materials using an animal model. Qualitative histology was performed on undecalcified 
 
*
 corresponding author: jmolive@fe.up.pt 
Materials Science Forum Vols. 455-456 (2004) pp. 374-377
online at http://www.scientific.net
© (2004) Trans Tech Publications, Switzerland
All rights reserved. No part of contents of this paper may be reproduced or transmitted in any form or by any means without the
written permission of the publisher: Trans Tech Publications Ltd, Switzerland, www.ttp.net. (ID: 138.243.195.38-01/10/06,11:59:14)
 Title of Publication (to be inserted by the publisher)   375 
 
 
 
sections at the bone defect area to evaluate the extent of new bone formation. SEM analysis was 
additionally used to characterise the new bone-implant interface. 
Materials and Methods  
Implant materials. Bonelike

 block samples were prepared with the size of 10 x 10 x 3mm
3
 by 
mixing in methanol hydroxyapatite (HA), Ca10(PO4)6(OH)2, supplied by Plasma Biotal (batch P201 
R) with a 4wt% of P2O5-based glass as previously described by Santos et al [9]. The slip was dried, 
sieved to < 75µm and uniaxially pressed at 288MPa followed by sintering at 1300ºC with a ramp 
rate of 4ºC/min and 1h dwelling time. Bonelike

 granules were also prepared for animal 
implantation with size ranging from 150 to 500µm using standard milling and sieving techniques. 
Bonelike

 samples were degreased, washed with deionised water and coupled to                      
poly(D,L-lactide-co-glycolide) 85:15 (PLGA) using a post-hybridisation method with solvent 
evaporation followed with heat treatment at 120ºC in vacuum for about 8hrs. 
 
Implantation procedure. Prior to implantation Bonelike

 samples were sterilized by soaking in 
several ethanol solutions (p.a.) and dried in a vacuum dessicator for 12hrs. In vivo studies were 
performed at the Japan SLC Inc. using a total of 10 White Japanese male rabbits weighting ~2kg at 
the time of implantation. A 50mg/ml pentobarbital sodium aqueous solution (Tokyo Kasei Kogyo 
Co., Ltd., Tokyo, Japan) was used as the general anaesthetic and 1.0mL/kg
 
was intravenous 
administrated in rabbit ear. The skin of the rabbit was shaved, cleaned and disinfected.  
Two separate midline incisions, each with 20mm long, were made on the back of the animals using 
a standard procedure in aseptic conditions. Bonelike

 samples were inserted through the incisions 
into the subcutaneous space without fixation and skin was closed with a Nesco suture (AZWELL 
Inc., Osaka, Japan).  
 For tibiae implantation Lidocaine supplied by Takeda Chemical Industries Ltd., Osaka, Japan 
was used as the local anaesthetic and it was administrated bellow the knee joint. After this 
procedure, longitudinal incisions with 20mm long were performed at the anterior medial rabbit 
tibiae. Holes of =2.12mm were drilled through cortex into bone medulla with simultaneous 
washing with physiological saline solution (Otsuka Pharmaceutical Co., Ltd, Tokyo, Japan) to 
prevent tissue necrosis. After the haemorrhage has been controlled, holes were filled with 
Bonelike

 granules and then periosteum and skin were closed in layers.  
Animals were sacrificed with an overdose of general anaesthetic after the 4 week period. The rabbit 
skin and tibiae were removed from animal for histological examination.  
 
Histological examination. The implanted area was sectioned, washed with physiological saline 
solution, fixed in 10% formalin/phosphate buffered solution, dehydrated with a graded series of 
alcohol solutions (70, 80, 90 and 100%) and embedded in methylmethacrylate resin. Thin sections 
with 150µm were cut perpendicularly to the tibiae axis with a diamond blade microtome (Struers 
Accutom) and hand-ground to approximately 70-80µm.  Some slices were stained with Solo-
Chrome R and haematoxylin-eosin for histological examination under light microscopy, while 
others were characterized by Scanning electron microscope (JEOL JSM-6301F) analysis. SEM 
specimens were coated with gold (Au) using a Fine Coater Ion Sputter (JEOL JFC-1100) before 
analysis. The elemental analysis was determined using an X-ray spectrometer (EDX) (NORAN-
VOYAGER) attached to the JEOL 6301F microscope. 
Results  
After the 4 week period of subcutaneous implantation a fibrous capsule surrounding the implants 
was observed for both Bonelike

 and Bonelike

/PLGA hybrid. No evidence of infection or 
inflammatory reaction was detected at the implantation sites.  
Histological studies demonstrated that after 4 week implantation in rabbit tibiae, new bone was 
formed fully attached to Bonelike

 and Bonelike

/PLGA hybrid granules (Fig. 1A-B), although 
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some gaps could be seen (Fig. 1A). The haematoxylin-eosin staining allowed observing new bone 
formation with various calcification densities in the surrounds of Bonelike

 granules, i.e. non-
mineralised or immature bone and mineralised bone as well as the vascularized de novo bone (Fig. 
2A-B).  
 
 
 
Fig. 1. Light microscopy photographs of 
Bonelike

 granules (G) implanted in rabbit 
tibiae for 4 weeks at the bone defect area. 
Extensive new bone formation among 
granules may be observed for: Bonelike
 
(A) and Bonelike

/PLGA hybrid (B). New 
bone (NB), non-mineralised bone 
osteoid (arrows) and PLGA (P). 
(Undecalcified section, Solo-Chrome R 
stain, original magnification x100).  
 
SEM studies showed new bone in perfect contact with Bonelike

/PLGA hybrid granules (Fig. 3A-
B). Ingrowth of new bone was detected at resorption areas in Bonelike
®
 granules (Fig. 3A). EDX 
analysis showed that new bone is slightly deficient in Ca and P elements compared to Bonelike
®
 
granules (Fig. 3B). 
Discussion  
Observation of the implant sections revealed extensive growth of newly formed bone tissue around 
Bonelike

 granules confirming previous results, which showed that Bonelike

 is highly 
osteoconductive biomaterial [11].  
 
 
 
 
Fig. 2. Light microscopy photographs 
of Bonelike

 granules (G) implanted 
in rabbit tibiae for 4-week at the bone 
defect area. Extensive new bone 
formation among granules may be 
seen for: Bonelike

 (A) and 
Bonelike

/PLGA hybrid (B). 
Immature bone (IB) and mature bone  
(MB) recruits many multinuclear cells 
attached to the material (Undecalcified 
section, Haematoxylin-eosin stain, 
original magnification x100).  
 
 
These results confirmed that the PLGA phase did not modified significantly the osteoconductive 
properties of Bonelike

. Bonelike
 
resorption was also observed with simultaneous new bone 
ingrowth, which may be due to the presence of degradable -tricalcium phosphate (TCP), 
Ca3(PO4)2, and -TCP phases. This result is strongly encouraging, since the Bonelike

/PLGA 
hybrid materials have been designed for local drug delivery while supporting new bone formation. 
After the 4 week implantation period, Ca and P profile at implant-new bone interface showed that 
materials were perfectly osteointegrated. 
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Fig. 3. (A) Backscattered scanning 
electron image of Bonelike

/PLGA 
hybrid granules, after a 4 week 
period, at implant (G)-new bone 
(NB) interface, showing areas of 
Bonelike
®
 resorption with new bone 
ingrowth (white arrows) and (B) 
SEM/EDX elemental analysis of Ca 
and P distribution at new bone 
(NB)-implant (I) interface (black 
arrows) obtained at the line profile. 
 
Conclusions 
In vivo evaluation of Bonelike

 and Bonelike

/PLGA hybrid for a 4-week period showed extensive 
formation of new bone and vascularization de novo bone. Bonelike
 
supports bone remodelling 
with simultaneous material degradation and new bone formation. 
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